Life Sciences
Glyph understands the challenges faced by biotech, medical device and pharmaceutical companies when launching products in global markets. Our comprehensive life science solutions assist you in complying with regulatory standards worldwide and improving your time-to-market, while supporting multilingual corporate and media communications.
Solution Components
- High-quality technical translation & in-country review
- Highly specialized medical translators
- Knowledge of regulatory standards
- European Union Directives
- Medical Device Directive 93/42/EEC (MDD)
- In Vitro Diagnostic Medical Device Directive 98/79/EEC (IVDD)
- Active Implantable Medical Device Directive 90/385/EEC (AIMDD)
- Directive 2004/27/EC concerning human medicines
- CE Marking
- Japanese product-liability legislation
- China's GB18030
- Multilingual print and online publishing expertise
- Quality Assurance protocols
Localized Results
- Labeling
- Packaging
- Instructions for Use (IFU)
- Summary of Product Characteristics (SPC)
- Patient Information Leaflet (PL)
- Technical documentation
- Training materials
- Web content
- Clinical trial protocols
- User interface for device software
- Scientific articles
- Marketing collateral
- Presentations
- Product registration dossiers
